JPRN-UMIN000012730已完成未知
Prospective, single-center, and exploratory study of temozolomide and rituximab for relapsed/refractory central nervous system lymphoma. - Temozolomide and rituximab for relapsed/refractory central nervous system lymphoma.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Presence of uncontrollable infection. 2. Positive for serum anti-HIV antibody. 3. Positive for serum anti-HBV antigen or elevated serum HBV-DNA level.
研究者
相似试验
招募中
3 期
Temozolomide and rituximab for relapsed/refractory central nervoussystem lymphoma.relapsed/refractory central nervous system lymphomaLymphomaJPRN-jRCTs031180374Taoka Kazuki10
招募中
不适用
A single-center, prospective, observational study investigating the levels of insulin antagonist hormones on diabetic ketosis and hyperglycemic emergencies on admissiodiabetes mellitusdiabetic ketosis, diabetic ketoacidosis, hyperosmolar hyperglycemic stateD003920JPRN-jRCT1030200267Suzuki Agena30
已完成
不适用
Examination of the level of insulin antagonist hormones in hyperglycemic emergencies on admission.diabetes mellitusJPRN-UMIN000046105Kitasato University, School of Medicine27
尚未招募
Unknown
Accuracy of continuous glucose monitoring in cardiac surgeryKCT0009396The Catholic University of Korea, Seoul St. Mary's Hospital42
尚未招募
Unknown
A single-center, prospective, randomized, exploratory study to investigate the influence of ARNI (angiotensin receptor neprilysin inhibitor) in patients with hemodialysis and heart failure: SPREAD trialChronic heart failureJPRN-UMIN000050122Masuko Memorial Hospital374